Pain Pump / Intrathecal Drug Delivery Insurance Denied? How to Appeal

An intrathecal drug delivery system (IDDS) — commonly called a pain pump — delivers medication directly into the intrathecal space surrounding the spinal cord, allowing effective pain control at a fraction of the oral or systemic dose. For patients with severe chronic pain who have failed conventional therapies, or cancer patients unable to tolerate the systemic side effects of opioids, an IDDS can be transformative. When insurers deny coverage, the denial is rarely justified when the clinical criteria are properly documented. Here is how to build a successful appeal.

Why Insurers Deny Pain Pumps

Insurance denials for intrathecal drug delivery systems follow a predictable pattern of justifications, most of which are reversible with comprehensive documentation.

"Not medically necessary" is the most common denial reason. Insurers typically require that patients have failed multiple conservative treatments before approving an IDDS. The Polyanalgesic Consensus Conference (PACC) guidelines — the gold standard for intrathecal drug delivery patient selection, published in the journal Neuromodulation — define specific criteria for appropriate IDDS candidacy. If your insurer cites a clinical policy, compare it against the current PACC guidelines. Many insurer policies are less rigorous than the PACC criteria actually require, meaning a patient who meets PACC criteria should generally meet the insurer's criteria as well.

Inadequate documentation of failed conservative treatments is the most common clinical stumbling block. Most insurers require documented failure of at least two to three oral opioid medications at therapeutic doses (for non-cancer pain) before approving an IDDS. If the medical record does not explicitly document which medications were tried, at what doses, for how long, and why each was considered a failure — the insurer will deny the claim. This is a documentation problem, not a clinical one, and it is fixable.

Missing or inadequate psychological evaluation is another common denial ground. Most clinical criteria for non-cancer pain IDDS candidates require a pre-implant psychological evaluation to assess candidacy. If this evaluation was performed but not included in the Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization request or appeal, the omission can drive the denial.

Denial of the intrathecal trial as a precondition to permanent implant is common. Most insurers require a positive intrathecal trial (CPT 62362 for temporary intrathecal catheter, CPT 62360 for trial with drug infusion) before approving permanent implantation. If the trial results were not submitted in sufficient detail — including pre-trial and post-trial pain ratings using a validated scale such as the Numeric Rating Scale (NRS) — the insurer may deny permanent implantation.

Experimental or investigational classification is sometimes applied to IDDS for specific indications. Intrathecal opioid therapy for chronic non-cancer pain and cancer pain is well-established and supported by decades of evidence; an "experimental" denial in this context is difficult to defend and should be challenged with PACC guideline citations and peer-reviewed literature.

How to Appeal an IDDS Denial

Step 1: Identify the Specific Denial Basis

Read your denial letter and EOB)" class="auto-link">Explanation of Benefits (EOB) carefully. Identify whether the denial is based on: inadequate conservative treatment trials; missing psychological evaluation; inadequate trial documentation; experimental classification; or a specific insurer coverage criterion that differs from PACC guidelines. The specific basis determines which documentation you need to gather. Request the insurer's complete clinical coverage policy for intrathecal drug delivery systems — you are entitled to it under ERISA (29 C.F.R. § 2560.503-1) or applicable ACA regulations.

Step 2: Compile a Comprehensive Medication History

Create a detailed, chronological list of every pain medication tried, including: drug name and formulation; starting and maximum dose achieved; duration of the trial; reason for discontinuation (inadequate analgesia, intolerable side effects, toxicity, drug-drug interaction); and the treating physician's clinical assessment of the outcome. This list must be specific enough that the insurer's medical reviewer can confirm that a genuine, sustained medication trial occurred. Generic statements that "opioids were tried without success" are insufficient.

Step 3: Document the Intrathecal Trial Results

Include the full documentation of your intrathecal drug trial: the pre-trial pain score (NRS), functional assessment baseline, the specific drug and dose used in the trial, the trial duration, the post-trial pain score, any functional improvement observed, and the treating pain management physician's clinical interpretation confirming a positive trial result. If the trial was conducted according to PACC-recommended protocols, state that explicitly.

Step 4: Obtain a Detailed Letter from Your Pain Management Specialist

Ask your treating pain management physician to write a letter that: documents your diagnosis using ICD-10 codes (for example, G89.29 for other chronic pain, M54.5 for low back pain, G89.3 for neoplasm-related pain in cancer cases); explains your specific clinical history and the failure of prior treatments; cites the PACC guidelines and how your case meets the patient selection criteria; summarizes the trial results; and includes the psychological evaluation report confirming candidacy. This letter is the centerpiece of your appeal.

Step 5: Submit Your Formal Written Appeal

File a written appeal addressing the insurer's specific denial reasons. For each denial ground, provide a direct response: if the insurer claims inadequate medication trials, provide the detailed medication history from Step 2; if the insurer cites a missing psychological evaluation, attach the full report; if the insurer claims the trial results were inadequate, provide the detailed trial documentation from Step 3. Cite the PACC guidelines throughout. For ERISA plans, you generally must exhaust internal appeals before requesting External Independent Review: Complete Guide" class="auto-link">external review.

Step 6: Request Independent External Review

If your internal appeal fails, request external IRO review. Select a reviewer with pain management or anesthesiology expertise. External reviewers in pain medicine apply PACC criteria and peer-reviewed evidence — not simply the insurer's coverage policy — and frequently find for policyholders when the clinical documentation is complete and the PACC criteria are met. External review is free and binding.

What to Include in Your Appeal

• The insurer's denial letter and coverage policy for intrathecal drug delivery systems, obtained from the claim file
• Detailed medication history documenting all prior opioid and non-opioid trials with specific drugs, doses, durations, and documented failure reasons, using ICD-10 codes for your underlying pain diagnosis
• Pre-implant psychological evaluation report confirming IDDS candidacy
• Intrathecal trial documentation: pre- and post-trial NRS pain scores, functional assessments, drug and dose used, and treating physician's clinical interpretation
• Treating physician's letter citing the PACC guidelines published in Neuromodulation and explaining how the patient meets the patient selection criteria

Fight Back With ClaimBack

Intrathecal drug delivery denials are almost always a documentation problem — the clinical criteria are well-established, the evidence base is strong, and the PACC guidelines provide a clear framework. The key is translating the patient's full clinical picture into a precise appeal that directly addresses the insurer's stated denial grounds. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal